Yüklüyor......
Apatinib in refractory radiation-induced brain edema: A case report
RATIONALE: Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has observed to be effective and safe in refractory radiation-induced brain edema, like Avastin did. Till now, there is no case report after apatinib came in the market. PATIENT CO...
Kaydedildi:
| Yayımlandı: | Medicine (Baltimore) |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Health
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5704783/ https://ncbi.nlm.nih.gov/pubmed/29145238 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000007358 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|